Recently, Yoshimoto et al. (29) reported a meta-analysis of 311 published human genome array datasets determined that the minimal prostate cancer-associated PTEN deletion at 10q23.3 corresponds to a ∼2.06 Mb region flanked by the BMPR1A and FAS genes. This evidence concerns the gene PTEN and prostate carcinoma.